Defibrotide (DF) appears effective and safe in a phase II, randomized study of patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT).
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Richardson, PG; Soiffer, R; Antin, JH; Vredenburgh, J; Kurtzberg, J; Martin, PL; Hockenbery, D; Steinbach, G; Murray, K; Vogelsang, G; Chen, A; Warren, DL; Momtaz, P; Wei, LJ; Jin, Z; Rifai, N; Bradwin, G; Iacobelli, M; McDonald, GB; Guinan, EC
Published Date
- November 16, 2002
Published In
Volume / Issue
- 100 / 11
Start / End Page
- 112A - 112A
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 0006-4971
Conference Name
- 44th Annual Meeting of the American-Society-of-Hematology
Conference Location
- PHILADELPHIA, PENNSYLVANIA
Conference Start Date
- December 6, 2002
Conference End Date
- December 10, 2002